³ÉÈË¿ìÊÖ

The Scottish Government is aware that supplies of some attention deficit hyperactivity disorder (ADHD) medicines continue to be intermittent. The supply of medicines, including those for the treatment of ADHD, and the associated legislation are a reserved matter for the UK Government, and we continue to engage with them on these supply issues.

The Chief Pharmaceutical Officer (CPO) for Scotland is a member of the UK-wide Medicines Shortage Response Group (MSRG). The MSRG has been set up to identify and co-ordinate responses to medicines shortages across the UK and provides advice to clinicians on alternative therapeutic options as appropriate. Prescribers and pharmacists have access to a medicines supply tracking tool which provides advice on each shortage, including alternative treatment options.

The NHS in Scotland has robust processes in place to manage supply issues when they do arise and normally there are alternative products which can be prescribed and dispensed. Scottish Government officials are working closely with all Health Boards and other stakeholders to help manage the supply disruptions with ADHD medicines and provide support when needed.

The CPO held a roundtable meeting with key stakeholders in Scotland in November 2024 to better understand the impact of ADHD medicine shortages locally and to determine if there is any further action that can be taken to strengthen our response. Following the meeting the CPO wrote to Health Boards to provide further background on medicines shortages more generally, how they are managed, and to clarify the current position on ADHD prescribing.

The sets out the seven standards for all services to support children and young people with neurodevelopmental support needs, including ADHD. The Scottish Government does not currently have any plans to publish specific minimum standards for ADHD post-diagnostic support.

I recognise that there has been a significant increase in children and adults seeking ADHD assessments across Scotland, and that this is creating challenges for a range of services.

The Scottish Government is working with the National Autism Implementation Team (NAIT) to develop national Adult Neurodevelopmental Pathways, building on the pilots we funded in four NHS Board areas and the subsequent learning and recommendations.

We are also continuing to work with NHS Health Boards, including NHS Ayrshire and Arran, and local authorities to support implementation of the National Neurodevelopmental Specification for Children and Young People. We have recently undertaken a review of the implementation of the Specification and established a new Neurodevelopment Taskforce to drive forward identified recommendations.

In addition to investment through Health Boards, we will also be providing £500,000 additional funding in 2025-26 to improve access to neurodevelopmental support for children and young people, including for ADHD assessments. This is in addition to £250,000 provided in 2024-25, which funded a range of individual projects to improve neurodevelopmental assessment and support for children and young people, including projects that support ADHD diagnosis.

The Scottish Government does not currently have any plans to develop a standard post-diagnostic support pathway for ADHD. The sets out the standards for all services to support children and young people with neurodevelopmental support needs, including ADHD. The Scottish Government is also working with the National Autism Implementation Team (NAIT) to develop national Adult Neurodevelopmental Pathways.

In addition, local authorities have duties under the Additional Support for Learning Act (Scotland) 2004 to identify, provide for and review the additional needs of their pupils. Under the Act an additional support need can arise for any reason and a diagnosis of ADHD is not required before support is put in place.

The Scottish Government is clear that support should be put in place to meet a child’s requirements when they need it. This includes community-based supports and where additional support is needed for learning. However, we recognise that in the case of ADHD, medication can be helpful, and a diagnosis is required to access this. We are working with Boards to ensure that children, young people and adults can access diagnostic services in a timely manner.

The Scottish Government does not hold this information centrally.

However, we acknowledge that work is needed to improve the quality of data on neurodevelopmental support and services, including a better understanding of current levels of need and the level of support people currently receive.

We are working with Health Boards and local authorities to improve our understanding of the available data, and how this could be used to support improvements for adults, children and families.

The Scottish Government does not currently have any plans to publish national service standards for ADHD assessment, treatment and support.

The sets out the seven standards for all services to support children and young people with neurodevelopmental support needs, including ADHD.

The Specification takes a needs-based approach to providing neurodevelopmental support. It is underpinned by principles of GIRFEC and intended to be delivered by all children’s services partners through a multi-agency approach.

I refer the member to the answer to question S6W-39413 on 6 August 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at /chamber-and-committees/written-questions-and-answers.

The Scottish Government does not currently have any plans to publish a national ADHD strategy.

However, the Learning Disabilities, Autism and Neurodivergence (LDAN) Bill consulted on proposals to introduce a National Strategy for Learning Disabilities and Neurodivergence, supported by local strategies and/or local delivery plans and underpinned by Statutory Guidance. Proposals also included requirements for regular reviews of both national and local strategies, the involvement of lived experience in the development of these strategies and an accountability mechanism to measure effectiveness of strategies.

We have been committed to taking a human rights-based approach to this legislation. This means that the consultation was fully co-designed with people with lived experience via the Lived Experience Advisory Panel (LEAP).

The public consultation closed on 21 April 2024 and received nearly 900 responses during the four months that it was open. This demonstrates the relevance and importance of this legislation for the people of Scotland.

The Scottish Government is continuing work to develop the proposals for the LDAN Bill, and is committed to publishing draft provisions. As before, we will work in partnership with the LEAP members whose support has been invaluable, and the LEAP will be at the heart of our process. In addition, we will meet with individual organisations with an interest whenever that is helpful.

The Scottish Government engages regularly with all health boards regarding their provision of support for neurodivergent people, including those with ADHD.

We are working closely with Health Boards and local authorities towards implementing the National Neurodevelopmental Specification for Children and Young People in full. The Scottish Government is also working with the National Autism Implementation Team (NAIT) to develop national Adult Neurodevelopmental Pathways.

We acknowledge that work is needed to improve the quality of data that we have on neurodevelopmental support and services, including for ADHD. We are continuing to work with Health Boards and local authorities to improve our understanding of what data is available, and how this could be used to support improvements.

The Scottish Government has directly allocated £123.5 million to NHS Boards and IJBs for the Enhanced Mental Health Outcomes Framework in 2025-26. This provides a single, flexible funding stream to support continued improvements and better outcomes across a range of mental health and psychological services in line with the Mental Health and Wellbeing Strategy. This includes funding for adult and child neurodevelopmental services, including services providing ADHD assessments.

In addition to investment through Health Boards, we will also be providing £500,000 additional funding in 2025-26 to improve access to neurodevelopmental support for children and young people, including for ADHD assessments. This is in addition to £250,000 of funding in 2024-25 to improve neurodevelopmental assessment and support for children and young people, including improving access to ADHD assessments.